Risk-factor control was poorer in female patients, who had a lower likelihood of reaching LDL and physical activity targets.

Patients at high risk for pulmonary complications had similar support needs at 90 days with HFNOT or standard oxygen.

The IMPACTS-BP trial showed that SPRINT-like reductions in systolic BP are possible even in tough real-world scenarios.

Among patients with a single CTO lesion, the study found an improvement in health status compared with medical therapy.

TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting the next wave of ...

Helping patients get groceries and make meals while staying on a DASH-approved diet not only helped, but people liked it, too ...

The lack of effect on different measures of coronary plaque reinforce the need for a large CV outcomes trial in these ...

Kenneth Rosenfield, Erik Klok, and Stavros Konstantinides join Mamas Mamas to discuss ultrasound-facilitated, ...

The benefit of digoxin was driven by reduced risk of new-onset or worsening HF hospitalizations, just like its benefit in ...

The consistent underrepresentation of African populations in clinical studies is a ‘crisis of scientific validity,’ Bamba ...

Low-income patients receiving a debit card spent most of the money on things upstream of medical care like food and utilities ...

Robert Yeh talks with host Yael L. Maxwell about forging new paths in cardiovascular research and learning how to turn down ...